Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Pharmaceutics
|
May 30, 2019
Drug Delivery Technology to the CNS in the Treatment of Brain Tumors: The Sherbrooke Experience
David Fortin
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
December 17, 2003
Altering the properties of the blood-brain barrier: disruption and permeabilization
David Fortin
Neurosurgery
|
July 21, 2010
Brain tumor headaches: from bedside to bench
Philippe Goffaux, David Fortin
Current Cancer Drug Targets
|
June 17, 2015
Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous
Annie Drapeau, David Fortin
Methods in Molecular Biology (Clifton, N.J.)
|
November 18, 2010
Blood-brain barrier disruption in the treatment of brain tumors
Marie Blanchette, David Fortin
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
January 18, 2006
Intracranial invasion of a basal cell carcinoma of the scalp
David Mathieu, David Fortin
Current Clinical Pharmacology
|
August 12, 2008
Chemotherapy and delivery in the treatment of primary brain tumors
David Mathieu, David Fortin
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
June 2, 2006
The role of chemotherapy in the treatment of malignant astrocytomas
David Mathieu, David Fortin
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
June 17, 2004
A blood-brain barrier disruption model eliminating the hemodynamic effect of ketamine
David Fortin, Robert Adams, Ariane Gallez
Journal of Neuroscience Methods
|
April 24, 2012
A new method of quantitatively assessing the opening of the blood-brain barrier in murine animal models
Marie Blanchette, Karine Michaud, David Fortin
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Pharmaceutics
|
May 30, 2019
Drug Delivery Technology to the CNS in the Treatment of Brain Tumors: The Sherbrooke Experience
David Fortin
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques
|
December 17, 2003
Altering the properties of the blood-brain barrier: disruption and permeabilization
David Fortin
Neurosurgery
|
July 21, 2010
Brain tumor headaches: from bedside to bench
Philippe Goffaux, David Fortin
Current Cancer Drug Targets
|
June 17, 2015
Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous
Annie Drapeau, David Fortin
Methods in Molecular Biology (Clifton, N.J.)
|
November 18, 2010
Blood-brain barrier disruption in the treatment of brain tumors
Marie Blanchette, David Fortin
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
January 18, 2006
Intracranial invasion of a basal cell carcinoma of the scalp
David Mathieu, David Fortin
Current Clinical Pharmacology
|
August 12, 2008
Chemotherapy and delivery in the treatment of primary brain tumors
David Mathieu, David Fortin
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
June 2, 2006
The role of chemotherapy in the treatment of malignant astrocytomas
David Mathieu, David Fortin
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
June 17, 2004
A blood-brain barrier disruption model eliminating the hemodynamic effect of ketamine
David Fortin, Robert Adams, Ariane Gallez
Journal of Neuroscience Methods
|
April 24, 2012
A new method of quantitatively assessing the opening of the blood-brain barrier in murine animal models
Marie Blanchette, Karine Michaud, David Fortin
Page
of 9